Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Donation of placenta to collect mitochondria for future mitochondrial augmentation therapies

Official title: Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies

Run by Minovia Therapeutics Ltd. · NCT03762512 · Data updated 2026-11-12

This project collects placentas donated by healthy women having elective C-section deliveries so mitochondria can be harvested for possible future mitochondrial augmentation therapies.

More Pregnancy Related trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment300 (estimated)
SponsorMinovia Therapeutics Ltd.
Industry-sponsored
Locations1 site (Ramat Gan)
StatusRecruiting
StartedDecember 1, 2018
Main results expectedDecember 2027
Study endsMarch 2028
Registry record updatedOctober 8, 2026
Trial IDNCT03762512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy pregnant women aged 18–45 planning an elective C-section at 36–41 weeks with an uncomplicated pregnancy and available medical history.

Probably not a fit

Women who are positive or at risk for communicable diseases, have complicated pregnancies, heavy tobacco or alcohol use, or who do not plan an elective C-section are unlikely to qualify or benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program enrolls healthy pregnant women aged 18–45 who plan an elective C-section between 36 and 41 weeks and who have uncomplicated pregnancies. Donated placentas are screened for infectious risks and relevant medical history before collection. Mitochondria are isolated from collected placentas and stored for research and potential future therapeutic use. There is no intervention to the donor beyond consent and standard delivery care.

Why it matters

Potential benefit: If successful, the collected mitochondria could support development of mitochondrial augmentation therapies that may help people with mitochondrial disorders.

How similar studies have gone: Related approaches to mitochondrial isolation and augmentation have shown promise in preclinical work and very early human studies, but broad clinical benefit remains unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy pregnant females between the age of 18-45, judged to be medically eligible by the Investigator and the Sponsor's Medical Monitor.
2. Planned elective C-section at weeks 36-41 of pregnancy.
3. Uncomplicated pregnancy as determined by the Investigator.
4. Available Medical History of the donor (diagnosis, diseases, medication etc…)

Exclusion Criteria:

1. Donor is positive for a communicable disease, such as: HBV, HCV, HIV 1\&2, WNV, HTLV 1\&2, Treponema pallidum, CMV, Chagas, Chlamydia Trachomatis, Neisseria Gonorrhea, or any other tests required by the medical facility, IMoH, FDA, EMA or the Sponsor.
2. Donor is at risk for a communicable disease as assessed by medical history, medical records, physical exam, and the Donor Screening Questionnaire.
3. Donor is at risk for COVID-19 as assessed by medical history, medical records, physical exam, and the COVID-19 Screening Questionnaire.
4. Donor smokes more than one pack of cigarettes a day or drinks more than one alcoholic beverage a day.
5. Donor has taken a medication with potential mitochondrial effects within 2 weeks prior to placental donation, such as valproic acid, aminoglycoside antibiotics, neuromuscular blocking drugs (See Appendix 3).
6. Donor has current or history of malignancy.
7. Donor has current or history of insulin dependent diabetes
8. Donor has current gestational diabetes treated with insulin, or pre-eclampsia.
9. Donor is known to be a carrier of a primary mitochondrial disease.

Where it's running

  • Sheba Medical Center Hospital- Tel Hashomer
    Ramat Gan, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.